ConcertAI
ConcertAI is a privately held healthcare and life-sciences AI company providing predictive, generative, and agentic AI SaaS products alongside real-world, clinico-genomic and multimodal data solutions. Its principal focus is oncology, with offerings intended to support clinical development, clinical-trial optimization, research, and advanced oncology insights. The company characterizes its market position as a leader in oncology-focused generative and agentic AI SaaS and healthcare/life-sciences real-world data solutions. In a January 2024 company release, it described its oncology and hematology real-world-data asset as the largest multimodal dataset of its kind; this is a company claim, not independently verified here.
Company Details
- Website
- concertai.com
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2018
- Funding
- More than $230M through Series C (company-reported, January 2025). Third-party company databases rep
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring